LyndaCSchneiderMD

Clinical & Laboratory Immunology

Professor of Pediatrics, Harvard Medical School

Dr. Schneider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
300 Longwood Ave
Boston, MA 02115
Phone+1 617-355-6180

Fax+1 617-730-0310

PubMed

13 citations
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.
Christopher H. Arehart, Michelle Daya, Monica Campbell, Meher Preethi Boorgula, Nicholas M. Rafaels
The Journal of Allergy and Clinical Immunology. 2021-06-07
100 citations
Critical role of kallikrein in hereditary angioedema pathogenesis: A clinical trial of ecallantide, a novel kallikrein inhibitor
Lynda C. Schneider, William R. Lumry, Arthur B. Vegh, Anthony H. Williams, Tess Schmalbach
The Journal of Allergy and Clinical Immunology. 2007-08-01
43 citations
Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab.
Christina S.K. Yee, Sultan Albuhairi, Elizabeth Noh, Kristel El-Khoury, Shervin Rezaei
The Journal of Allergy and Clinical Immunology. in Practice. 2019-02-01

Journal Articles

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy
Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA
Original Article Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab
Dale T Umetsu, Rima Rachid, Jennifer LeBovidge, Lynda Schneider, ScienceDirect

Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and SensitivitiesJanuary 27th, 2021
Baby Food Products for Early Allergen Introduction Hit MarketMarch 14th, 2018
IL-31 Pathway May Lead to New Treatments for PruritusAugust 18th, 2017
Join now to see all

Immune Response To Varicella Vaccination In Subjects With Atopic DermatitisNational Center For Research Resources2007
Genetics Of Atopic Dermatitis - Eczema Herpeticum (ADEH) StudyNational Center For Research Resources2007
Genetic And Environmental Risk Factors In Atopic DermatitisNational Center For Research Resources2007
Advn Biomarker Registry StudyNational Center For Research Resources2007
Edema2:Evaluation Of Dx-88'S Effects In Mitigating Angioedema, An OPEN Label STDNational Center For Research Resources2004–2006
Dx-88 In Hereditary AngioedemaNational Center For Research Resources2004–2005
Vapor Heated C-1 Inhibitor Immunotherapy In HaeNational Center For Research Resources2000–2002
Study Of Budesonide Nebulizing Suspension &Placebo In Asthmatic ChildrenNational Center For Research Resources1997–1999
OPEN Label Extension To A Study Of Four Dose Regimens Of BudesonideNational Center For Research Resources1997–1999
Trial Of Nebulized Budesonide For Moderate Asthma In ChildrenNational Center For Research Resources1996